000 01562 a2200469 4500
005 20250517001516.0
264 0 _c20150424
008 201504s 0 0 eng d
022 _a1573-7276
024 7 _a10.1007/s10585-014-9685-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBollen, L
245 0 0 _aMolecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
_h[electronic resource]
260 _bClinical & experimental metastasis
_cJan 2015
300 _a1-5 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPhenotype
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, Progesterone
_xmetabolism
650 0 4 _aRetrospective Studies
650 0 4 _aSpinal Neoplasms
_xmortality
650 0 4 _aTriple Negative Breast Neoplasms
_xmetabolism
700 1 _aWibmer, C
700 1 _aWang, M
700 1 _avan der Linden, Y M
700 1 _aLeithner, A
700 1 _aBünger, C E
700 1 _aJensen, A B
700 1 _aFiocco, M
700 1 _aBratschitsch, G
700 1 _aPondaag, W
700 1 _aBovée, J V M G
700 1 _aDijkstra, P D S
773 0 _tClinical & experimental metastasis
_gvol. 32
_gno. 1
_gp. 1-5
856 4 0 _uhttps://doi.org/10.1007/s10585-014-9685-y
_zAvailable from publisher's website
999 _c24318882
_d24318882